Osimertinib for Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09) The systematic review included 35 publications on ...
The majority of fatal cases of pulmonary embolism in hospitalized patients occur in acutely ill, medically treated patients. Current guidelines, based on a large number of prospective, randomized, ...
Apixaban 2.5 mg twice daily significantly reduced symptomatic venous thromboembolism (VTE) recurrence, with a low risk of major bleeding, in patients with provoked VTE and enduring risk factors, ...
Apixaban 2.5 mg twice daily significantly reduced symptomatic venous thromboembolism (VTE) recurrence, with a low risk of major bleeding, in patients with provoked VTE and enduring risk factors, ...
MADRID, Spain—For patients who experience venous thromboembolism (VTE) provoked by surgery, immobility, or other factors and who face ongoing risk factors, 12 months of low-intensity apixaban (Eliquis ...
GAITHERSBURG, Md., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received a $30 million contract modification from the Biomedical Advanced Research ...
Hosted on MSN
Virgo Daily Horoscope Today, September 7, 2025: Mercury Warns, Pause Before Taking the Next Step
Today is about embracing your inner strength in a calm and grounded manner. You do not need loud gestures to show your power; your quiet confidence speaks for itself. Use this energy to bring balance ...
Donald Trump Health: The President of the United States (USA) is battling the worst symptoms of chronic venous insufficiency (CVI). With recent pictures making headlines showing POTUS' hands all ...
Normally, a 79-year-old man having a bruise on his hand wouldn’t be much of a story. But that changes when the septuagenarian in question is Donald Trump. Trump’s injury was first spotted weeks after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback